Our team
Justine Mann | BAppSc, MBA
Chief Executive Officer
Justine Mann is the Chief Executive Officer of CBE Pure Solutions, leading the organisation’s strategic direction and operational excellence in biopharma manufacturing and testing. With more than 25 years of senior technical and leadership experience across sterile manufacturing, microbiology and quality operations, she has built a global career spanning the pharmaceutical, biotechnology and medical technology sectors.
A former Director of the Centre of Biopharmaceutical Excellence and Pfizer Inc., Justine has provided high‑level regulatory, operational and compliance expertise to biopharmaceutical clients worldwide. She holds an MBA and has led major initiatives across Australia, USA, Europe and Asia, with deep capability in meeting FDA, EU and TGA PIC/S regulatory standards.
Justine also serves as a registered APVMA auditor and NATA technical assessor, and previously held the role of President of the PDA Australia Chapter.
“Contributing to MTP has driven my career, I am passionate about translating and generating medicines onshore that can profoundly impact human and animal healthcare and improve our national sustainability”
Nigel Baade | BCom, CPA, MAICD
Chief Financial Officer
Nigel Baade is a senior executive leader with deep experience across the pharmaceutical, biotechnology, and life sciences sector. With a career spanning more than three decades, he has held executive finance and governance roles with a broad range of responsibilities, including finance, commercial, legal, risk management, corporate governance, product supply, clinical trial and research contracts, IT and communications, within large and small publicly listed and private organisations.
Nigel has extensive experience in company strategy and financing, corporate initiatives and transactions, key commercial licensing, product supply contracts and grant funding within the sector.
Nigel served as Chief Financial Officer & Company Secretary at ASX-listed biotech Starpharma Holdings, where he played a central role in raising $100+ million in equity funds for clinical research, lead M&A transactions and go-to-market international strategies for newly developed products. He also provided financial advice on commercial licensing and research collaborations with international pharma companies. Earlier in his career, he held roles at Cerylid Biosciences and FH Faulding (now Pfizer), building a strong foundation in financial control, operational finance, and commercial decision‑making within pharma and healthcare manufacturing contexts.
In addition to executive leadership roles, Nigel has served as Director and Treasurer of the BioMelbourne Network. Nigel is a Certified Practising Accountant (CPA) and is a member of the Australian Institute of Company Directors.
Catherine Osborne | PhD, GAICD
Business Development Director
Catherine Osborne is a senior life sciences leader with more than 15 years’ experience across clinical trial services, laboratory operations, commercial strategy and business development. She has held executive roles in both emerging and established organisations, leading teams through operational scale‑up, accreditation, commercial transformation and complex stakeholder environments.
In her current role at CBE Pure Solutions, an Australian GMP manufacturer, Catherine contributes to the organisation’s strategic growth and industry engagement.Her experience includes serving as APAC General Manager for LabConnect, where she established the company’s first central laboratory in the region, and as CEO of Crux Biolabs, where she grew the organisation from a small academic testing service into an accredited commercial laboratory supporting global clinical trials. Earlier roles at Jomar Life Research, Thermo Fisher Scientific, CSIRO, Monash University and the University of California, Berkeley, span both scientific and commercial functions.
Catherine holds a PhD in Microbiology from the University of Melbourne and is a graduate of the Australian Institute of Company Directors. She is committed to strengthening Australia’s life sciences sector by building scientific capability, creating high‑skill jobs for researchers and technical specialists, and supporting the translation of research into real‑world improvements.
Robyn Hofer | BASci
Microbiology & Sterility Assurance Manager
Robyn Hofer is a seasoned microbiology and quality leader with more than 20 years of experience in pharmaceutical manufacturing. Her career spans major global organisations including Pfizer, Hospira, and Mayne Pharma, where she has built deep expertise in sterility assurance, environmental monitoring, validation, and regulatory compliance. Robyn’s technical grounding is matched by a strong operational mindset, shaped through hands‑on roles across microbiology laboratories and large‑scale sterile manufacturing environments.
Across her tenure at Pfizer and Hospira, Robyn progressed through leadership roles culminating in her position as QC Compliance Manager, where she oversaw quality systems, audit readiness, and site‑wide compliance programs. She has led multidisciplinary teams, guided complex investigations, and driven continuous improvement initiatives that strengthened product quality and operational reliability. Known for her calm, pragmatic leadership style, Robyn brings clarity to technical challenges and fosters high‑performing, quality‑focused teams.
Today, she is recognised for her ability to bridge scientific rigour with practical execution — a combination that has made her a trusted leader in regulated manufacturing environments.
Andrew Hoxey | BAppSc, MSc
Quality Manager
Andrew Hoxey is a quality and compliance leader with extensive experience working within large, global pharmaceutical organisations. His career has been shaped by leadership roles in GMP‑regulated environments, where he has been responsible for quality systems that support product integrity, regulatory compliance, and operational readiness across complex manufacturing operations.
Andrew has held senior quality roles at major pharmaceutical companies including CSL, Pfizer, and Hospira, where he developed deep expertise in quality management systems, deviation and CAPA management, audit and inspection readiness, and continuous improvement. He is recognised for his ability to embed quality into daily operations, working closely with manufacturing, engineering, and validation teams to ensure quality frameworks are practical, risk‑based, and aligned with business objectives.
Wayne Adcock | BApSci, PhD, Post Grad Dip BA
Product Development Manager
Wayne Adcock is a senior biologics and pharmaceutical operations leader with more than 30 years of experience spanning manufacturing, quality, R&D, operational excellence, and advanced data analytics. His career includes major leadership roles at CSL Behring, the Australian Red Cross Lifeblood, and advisory work across global biopharmaceutical and government organisations. Wayne is known for his energetic, pragmatic leadership style and his ability to drive quality, productivity, and continuous improvement across highly regulated environments.
At CSL Behring, Wayne held several executive roles over more than two decades, including Senior Director of Manufacturing & Operational Excellence, where he led plasma operations, antivenom production, and flu fill‑finish activities, overseeing more than 250 staff and a significant operational budget. His later roles — including National Quality Director at Lifeblood and consultant to leading healthcare organisations — further strengthened his reputation for strategic problem‑solving, regulatory expertise, and large‑scale organisational improvement.
Carlo Volpe | PhD
Production Manager
Carlo Volpe is a manufacturing and operations specialist with more than 20 years of experience across pharmaceutical and life sciences environments. His career has been built through hands‑on leadership in GMP‑regulated settings, spanning validation, fill‑finish, packaging, and large‑scale production operations within organisations including CSL, GSK, Hospira, and CSL Behring.
Across senior leadership roles, Carlo has managed complex manufacturing areas, led high‑performing production teams, and supported technology transfer, process optimisation, and continuous improvement initiatives. He is known for his ability to translate regulatory and operational requirements into practical, repeatable systems that enable safe, compliant, and reliable manufacturing outcomes.
At CBE Pure Solutions, Carlo contributes to the technical backbone of the organisation, applying his deep understanding of production workflows, facility operations, and regulatory expectations. With a science foundation from Monash University, he brings a steady, methodical, and collaborative approach, grounded in operational integrity and disciplined execution.
Jeff Davies | BSc(Hons) PhD
Chair of the Board
Jeff is a Biopharmaceutical Executive with over 40 years industry experience. As CSL’s Executive Vice President and General Manager for Asia Pacific, he had oversight and lead the plasma products, influenza vaccines, antivenoms, in-licensed vaccines, pharmaceuticals and the diagnostic businesses. This included oversight of major infrastructure projects for clinical trial and biological production facilities to TGA/FDA standards. He was a member of the due diligence team that resulted in CSL becoming a global company and prior to his GM roles was Global Head of Research and Development for CSL Behring, with oversight of R&D strategy and translation programs from R&D to commercialisation.
Jeff has held a number of senior advisory roles, including sitting on the Pharmaceutical Industry Council, the Australian Red Cross Advisory Board and Medicines Australia and other Board roles.
"I am excited to be part of CBE Pure Solutions: a company striving to provide essential infrastructure to support onshore development and manufacture of new medical therapies and diagnostics targeting global market.”
Andrew Watson | BEng
Board Member
Andrew has designed, constructed, qualified and operated cleanrooms over 25 years. As independent chair for Standards Australia ME-060 (Controlled Atmospheres), Andrew is the Australian recognised expert in cleanrooms and provides his expertise writing international standards. Andrew will oversee the project and ensure that the facility is designed, constructed and qualified to the required standards and build a sound strategic future for the business.
“CBE Pure Solutions embodies decades of experience in this industry. Our facilities, our processes and our approach to compliance respond to our vision - delivering the next generation of Life Science manufacturing.”
Andrew Carter | BSc, Grad Dip Bus, MCommLaw
Board Member
Andrew Carter is a company director and strategic advisor with more than 35 years’ experience in the health technology sector.
He is recognised for his expertise in the commercialisation and growth of life sciences and health technology companies.
Andrew founded Commercial Eyes Pty Ltd, which grew to become one of Australia’s leading health technology commercialisation firms prior to its acquisition by ProductLife Group in 2023.
Andrew invests in and advises emerging and established health technology companies and serves as a Chair, non executive director or advisor to a number of private and not-for-profit organisations.